The present invention relates to pharmaceutical formulations comprising specific hydrazidomycin compounds. Since said hydrazidomycin compounds show cytotoxic activities, the present invention further relates to said hydrazidomycin compounds for use in medicine, in particular in the treatment of proliferative disorders.
申请公布号
EP2526935(A1)
申请公布日期
2012.11.28
申请号
EP20110004267
申请日期
2011.05.24
申请人
ONCOTEST GMBH
发明人
FIEBIG, HEIN HERBERT, PROF. DR.;KELTER, GERHARD, DR.;MAIER, ARMIN, DR.;UEBERSCHAAR, NICO;TCHIZE NDEJOUONG, BASILE LE SAGE, DR.;DING, LING, DR.;HERTWECK, CHRISTIAN, PROF. DR.
